In patients with HER2-positive breast cancer, Tykerb (lapatinib) has been used both in combination with herceptin (trastuzumab) and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy treatment. ...
Jan 16, 2012
0
0
Blocking the action of vascular endothelial growth factor (VEGF) with the new anti-VEGF drug aflibercept can curb the development of malignant ascites (excessive fluid in the abdomen), a common and painful complication of ...
Dec 20, 2011
0
0
(Medical Xpress) -- Less overall radiotherapy, delivered in fewer but higher doses, is as safe as standard, lower doses for treating prostate cancer, according to new research published in the Lancet Oncology today (Tuesday).
Dec 13, 2011
0
0
Men with locally advanced or high-risk prostate cancer who receive combined radiation and hormone therapy live longer and are less likely to die from their disease, shows clinical research led by radiation oncologists at ...
Nov 3, 2011
0
0
Selecting better matched recipients and donors than is currently required for umbilical-cord blood transplantation could substantially reduce transplant-related deaths. The findings, published Online First in the Lancet Oncology ...
Oct 6, 2011
0
0
Cancer is one of the leading causes of death and morbidity worldwide, and its economic burden grows year by year. In 2008, the worldwide cost of cancer due to premature death and disability, excluding direct medical costs, ...
Sep 26, 2011
0
0
Intra-uterine devices designed to prevent conception may also protect against cervical cancer, according to a study covering more than 20,000 women that was released on Tuesday.
Sep 13, 2011
1
0
A vaccine routinely used to shield against cervical cancer caused by the human papillomavirus also reduces women's risk of anal cancer, a study published by the journal The Lancet Oncology on Tuesday says.
Aug 23, 2011
0
0
(Medical Xpress) -- Taller people are at increased risk of a wide range of cancers, according to new research led by Oxford University.
Jul 22, 2011
1
0
On the 25th anniversary of the Chernobyl nuclear disaster, a comment published by Lancet Oncology describes the known health consequences of the 1986 event. The authors are Kirsten B. Moysich, PhD, MS, and Philip McCarthy, ...
Apr 27, 2011
0
0
